Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma has announced successful resolutions at their General Meeting, with all motions carried. The company is moving forward with plans to shift its listing from the Secondary Listing to the Commercial Companies category, subject to the appointment of a sponsor and FCA approval. Shareholders have also provided the necessary approval for an eventual delisting from the ASX, contingent on the successful transition of listing categories.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.